https://orcid.org/0000-0002-2588-9366
References
- Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020 Mar 11:ii: S1201-9712(20)30123–5. [Epub ahead of print] Review. PubMed PMID: 32171952. doi:10.1016/j.ijid.2020.03.004.
- Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004;25(6):291–94. Review. PubMed PMID:15165741. doi:10.1016/j.tips.2004.04.001.
- Dua J, Rana A, Bhandari A. Liposome: methods of preparation and applications. Int J Pharm Stud Res. 2012;3:14–20. Review.
- Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst Rev. 2009;26(6):523–80. PubMed PMID:20402623; PubMed Central PMCID: PMC2885142. doi:10.1615/CritRevTherDrugCarrierSyst.v26.i6.10.
- Shah Mahmud R, Müller C, Romanova Y, Mostafa A, Ulyanova V, Pleschka S, Ilinskaya O. Ribonuclease from bacillus acts as an antiviral agent against negative- and positive-sense single stranded human respiratory RNA viruses. Biomed Res Int. 2017;2017. Article ID 5279065:11.
- Tomori Y, Iijima N, Hinuma S, Ishii H, Takumi K, Takai S, Ozawa H. Morphological analysis of trafficking and processing of anionic and cationic liposomes in cultured cells. Acta Histochem Cytochem. 2018 27;51(2):81–92. doi:10.1267/ahc.17021.